News Daily News Take Heed of Sex Differences in Peripheral Vascular Disease: AHA Michael O'Riordan March 13, 2025
News Daily News As More Peripheral Interventions Go Radial, the AHA Offers Some Insights L.A. McKeown December 12, 2024
News Daily News Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry Todd Neale October 16, 2023
News Daily News SCAD in Men: Canadian Study Sheds Light on Rare Condition Caitlin E. Cox October 25, 2022
News Daily News IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document L.A. McKeown August 05, 2022
News Daily News Intravascular Lithotripsy May Facilitate TAVI in Patients With PAD L.A. McKeown November 04, 2021
News Daily News More Insights Into AAA Genetics Spur New Questions on Screening Caitlin E. Cox September 29, 2020
News Daily News Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial Caitlin E. Cox June 18, 2020
News Daily News FDA: New Concerns Surface With Endologix Grafts for AAA L.A. McKeown October 28, 2019
News Daily News German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies L.A. McKeown October 09, 2019
News Daily News US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions Caitlin E. Cox June 18, 2019
News Daily News FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting Yael L. Maxwell June 18, 2019
News Daily News Supervised Exercise Plus Angioplasty Best for Intermittent Claudication: Meta-analysis Todd Neale June 03, 2019
News Daily News Terumo’s Solopath Transfemoral System and Recollapsible Balloon Access System Recalled for Dislodging Issues L.A. McKeown May 30, 2019
News Daily News Two Pediatric Cardiac Catheters Recalled for Defective Balloons L.A. McKeown April 26, 2019
News Daily News Guidelines for Peripheral Interventions Often Built on Shaky Foundation Caitlin E. Cox January 10, 2019
News Daily News New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration L.A. McKeown December 18, 2018
News Daily News FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies Michael O'Riordan December 06, 2018